Two case reports involving therapeutic monoclonal anti-CD47 (Hu5F9-G4), it's effect on compatibility testing and subsequent selection of components for transfusion
Transfus Med
.
2020 Apr;30(2):157-160.
doi: 10.1111/tme.12664.
Epub 2020 Jan 8.
Authors
Laura Reyland
1
,
Mark Dwight
1
,
Tom Bullock
1
,
Tom Latham
1
2
,
Karen Lord
2
,
Adele Wardle
2
,
Daniel Palmer
3
,
John Eggington
3
,
Therese Callaghan
3
,
Deborah Seals
4
,
Samar Kulkarni
4
Affiliations
1
NHS Blood and Transplant-Filton, Red Cell Immunohaematology Laboratory, Bristol, UK.
2
University Hospitals Bristol, NHS Foundation Trust, Blood Transfusion, Bristol Royal Infirmary, Bristol, UK.
3
NHS Blood and Transplant-Liverpool, Red Cell Immunohaematology Laboratory, Liverpool, UK.
4
The Christie NHS Foundation Trust, Blood Transfusion, Manchester, UK.
PMID:
31914482
DOI:
10.1111/tme.12664
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Monoclonal*
Antibodies, Monoclonal, Humanized
Blood Transfusion*
Humans
Substances
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
magrolimab